Does Creatine Really Help You Build Muscle and Get Stronger?

Why people believe this

Creatine is a compound your body makes and you also obtain from foods such as meat and fish. Much of it is stored in muscle. Its phosphocreatine system helps rapidly regenerate ATP, the energy used for muscle contraction, during short, demanding efforts.

That mechanism makes the claim plausible. The useful test, though, is whether people following a comparable training programme improve more with creatine than with placebo. A plausible energy pathway alone cannot tell us how much extra muscle someone will build.

What does the human evidence show?

Most participants in that review were men: 460 men and 49 women. The female subgroup did not show a statistically significant benefit, but it was much smaller. That does not establish that creatine only works in men, and the reported sex comparison did not conclusively demonstrate a difference between them.

The latest review corroborates the pattern, but its abstract was accessible while its full text was not. It is supporting context rather than the sole basis of this verdict. These reviews reuse some of the same trials: their participant totals must not be added together as independent evidence.

Power is the speed of producing work; strength is the force or load you can produce. Creatine is particularly useful for repeated brief, high-intensity efforts, where maintaining power or doing more work across bouts matters. It does not improve every performance test equally. A better training session is also a different outcome from bigger muscles months later. The AIS guidance recognises these specific performance applications.

More lean mass is not all new muscle

That trial highlights the measurement problem. It does not show that every creatine-associated gain is water or overturn the wider strength evidence. Nor did it test whether a higher dose would fix the result. The authors’ suggestion about doses above 5 g/day remains a hypothesis, not a demonstrated requirement.

Women, younger adults and older adults

Younger adults: much of the strength research is in younger or middle-aged men. Both trained and untrained people have been studied, but a pooled result cannot identify exactly who will benefit most.

Women: smaller female samples in older reviews reduce precision. A 2026 review of seven placebo-controlled trials in postmenopausal women reported about 0.37 kg additional lean mass and 7.5 kg additional leg-press strength; the strength analysis involved only three trials and 111 participants. The review was not prospectively registered and most trials had some bias concerns. Positive subgroup patterns involving dose and training do not prove a uniquely effective dose or a sex-specific rule.

Older adults: a separate 2026 synthesis of 11 trials in people aged 60 or over found a small additional strength benefit (standardised effect 0.31, 95% CI 0.18–0.45), rated moderate certainty. It found no clear additional muscle-mass or physical-function benefit; those outcomes had lower certainty. Participants were generally healthy, so findings should not automatically be transferred to frail people or those with sarcopenia.

These are overlapping bodies of research answering different questions. They support an optional exercise aid across adulthood, with unequal confidence in particular populations. They do not establish treatment for menopause symptoms, slower ageing or longer life.

The catch: an average is not your result

Response varies with starting muscle creatine stores, diet, adherence, training and the outcome being measured. Lower initial stores, as can occur with little dietary creatine, leave more room for stores to rise; that does not guarantee a larger visible transformation. Training programmes and trial durations vary, and many trials are small.

The strongest muscle-building case is creatine plus effective resistance training. Creatine can change muscle stores and water without training, but supplementation alone should not be expected to reproduce a training programme’s adaptations. You can become stronger and build muscle without taking it.

Fat-loss, brain-health and anti-ageing promises require their own evidence reviews. The newer broad exercise meta-analysis did not find a significant fat-mass benefit. A lower body-fat percentage can reflect more lean mass rather than less fat. This article’s exercise rating does not validate cognitive, hormonal or longevity claims.

Monohydrate, daily use, loading and timing

Creatine monohydrate is the form with the established research base. Claims that alternative forms such as hydrochloride, buffered creatine or ethyl ester build more muscle or work better at smaller doses are not established by comparable outcome evidence. A higher price or an absorption claim is not proof of superior training results.

Common studied maintenance protocols use 3–5 g/day. An optional loading phase often uses about 20 g/day in divided doses for five to seven days, followed by maintenance. Starting directly with maintenance increases stores more slowly, typically over about four weeks. Loading speeds that process; it is not compulsory.

The aim is sustained muscle stores, so daily consistency, including rest days, is a practical approach. Evidence does not establish a decisive universal advantage for taking it immediately before rather than after training. The protocols describe research and sports-nutrition practice, not an individual medical prescription. They do not imply that more is always better.

Safety: weight, stomach effects and kidneys

Conventional creatine monohydrate use is generally well tolerated in healthy adults. Initial weight gain can reflect increased muscle water, particularly with loading; it should not be labelled rapid muscle growth or fat gain. This can matter in weight-category sport or when interpreting a scale.

Some people experience bloating, diarrhoea or stomach discomfort, especially with large single doses. Smaller divided servings or avoiding loading can improve tolerability. Controlled research does not support the common claim that creatine routinely causes dehydration or cramps.

A 2026 review of 26 studies similarly distinguished lower creatinine-based estimates of filtration from the absence of a significant change using direct Cr-EDTA measurement or urine injury markers. These reassuring findings do not prove zero risk for every person or settle safety in established kidney disease.

Tell the clinician interpreting your blood tests that you use creatine; they may consider cystatin C, urine markers or other assessments. Do not dismiss an abnormal test yourself. Seek individual advice before use if you have kidney disease, reduced kidney function, pregnancy, or a medical condition or medication that makes supplementation more complex. Safety evidence in pregnancy is insufficient for a routine recommendation.

How trustworthy is the research?

This review prioritised randomised comparisons and systematic syntheses over mechanisms or testimonials. Some prominent creatine researchers disclose supplement-industry relationships. The strength and imaging reviews include industry-supported research or donations among author disclosures; the imaging review itself reported no external funding. The 2025 wash-in trial reported donated creatine despite no external research funding. The postmenopausal review disclosed industry links and manufacturer support for publication costs. The safety narrative review also disclosed industry relationships and manufacturer support for publication fees.

The 2026 older-adult review and 2025 kidney review reported no funding or relevant competing interests. Industry involvement does not automatically invalidate findings, but makes transparent methods, placebo controls, independent replication and attention to null results especially valuable. Not every cited source was available in full: abstract-only assessments are marked below, and unverified funding should not be assumed absent.

What this means for you

If your goal is strength and muscle, put a progressive resistance-training programme, adequate nutrition and recovery first. Creatine monohydrate is a reasonable optional addition for many healthy adults who want a possible extra training benefit. It is not essential, and the research does not predict your personal gain.

Assess progress through training performance and trends over time, rather than interpreting the first increase on the scale as new muscle. There is no need to buy a more elaborate form or to chase escalating doses. Suitability and tolerability matter as well as evidence.

Research & Sources

Evidence reviewed: October 2026. Research checked on 5 October 2026, including recent 2025–2026 publications. This is an editorial investigation, not an exhaustive systematic review. Reviews may include overlapping trials; totals have not been combined. Some full-text destinations were temporarily inaccessible, so those sources were assessed through their verified indexed abstracts.

Evidence vs Hype explains scientific research for educational purposes and does not provide individual medical diagnosis or treatment.